Date of Award

1-1-2013

Document Type

Thesis

Degree Name

M.A.

Department

Economics

First Advisor

Peter Ho

Keywords

Drug, Patent, Pharmaceutical

Abstract

This paper seeks to determine if extended patent terms can positively effect the production of drugs that treat rare diseases. It reviews the structure of the modern pharmaceutical company and considers the regulatory history that lead to this structure. The paper applies historically significant economic research in the field of patents and considers patent alternatives to establish the best method for incentivizing the development of these drugs. The paper finds that while there are numerous pitfalls and issues with the patent method, there are no viable alternatives. It also concludes that extending patent terms for drugs that treat rare diseases can act as a catalyst to orphan drug development.

Provenance

Recieved from ProQuest

Rights holder

Joanna Louise Thompson

File size

100 p.

File format

application/pdf

Language

en

Discipline

Economics

Share

COinS